HER2 positive gastric cancer: Who benefits from HER2 targeted therapy?

K. Kolbe, I. Haffner, K. Schierle, D. Maier, B. Geier, B. Luber, A. Kretzschmar, Fischer L. von Weikersthal, M. Ahlborn, J. Riera, B. Rau, G. Siegler, S. Fuxius, T. Decker, C. Wittekind, F. Lordick

Research output: Contribution to journalOriginal Articlepeer-review

Original languageUndefined/Unknown
JournalOncology Research and Treatment
Publication statusPublished - 2020

Cite this